Navigation Links
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Date:6/8/2011

ular Biology.  He has authored over 150 peer-reviewed research publications, and is the inventor on numerous issued and pending patents relating to dendritic cells.  Dr. Boynton is resuming his position as Chief Scientific Officer of NWBT.  

Mr. Les Goldman was a partner at the law firm of Skadden, Arps for over 30 years, specializing in a wide array of advanced technologies and their commercialization.  He helped build one of the preeminent global practices in this area.  He was responsible for advising on financing, regulatory strategies, and public outreach relating to his clients' development of numerous cutting edge technologies, bringing to bear a diverse range of deal-making skills.  He has taken a special early retirement from Skadden, Arps to enable him to undertake an executive role at NWBT.  Mr. Goldman also serves as an advisor to a number of other breakthrough technology companies.  In addition, for 8 years, Mr. Goldman has served as Chairman of the Board of a group of TV Stations in 4 mid-size cities across the country.  Mr. Goldman is joining NWBT as Senior VP Business Development.

Dr. Bosch joined NWBT in 2000, and has been serving as Chief Technical Officer for a number of years.  In this capacity, he plays a key role in the preparation and submission of the Company's regulatory applications, as well as ongoing development of the Company's product lines, and ongoing development and/or acquisition of new technologies.  Dr. Bosch led the process of designing the protocols, and managed the successful preparation and submission of the Company's INDs (applications for FDA approval to conduct clinical trials), for prostate cancer, brain cancer and five other cancers.  He also led the processes for other regulatory submissions in both the US and abroad (including the successful applications for orphan drug status in both the US and Europe for DCVax-L® for brain cancer).  He
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Northwestern chemists take gold, mass-produce Beijing Olympic logo
2. Northwest Secures US$1.0 Million Debt Financing
3. Northwest Secures US$1.65 Million Debt Financing
4. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Northwest Biotherapeutics Secures $700,000 Equity Financing
7. Sirius Genomics to Present at Invest Northwest Conference
8. Oncothyreon to present at Invest Northwest 2009
9. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
10. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
11. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Product and process impurities ... abundance and are often “lost in the noise,” ... Join presenters Dr. Rowel Tobias, Senior Scientist, Protein ... Head of Quality at Nanotherapeutics, Inc., to lear ... speed detection and quantitation while achieving the required ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Robert Harman, DVM, ... Medicine company, is proud to announce the relaunch of his ... with a new series called “ What are Stem Cells ... an honest and straightforward foundation in the basics of stem ... decision on the right type of treatment when considering regenerative ...
(Date:7/10/2014)... 10, 2014 On July 9 ... , presented Russia,s first national ... The Company is developing a unique project called ... develops a number of innovative drugs based on monoclonal ... ceremony took place at the International Exhibition "Innoprom 2014" ...
(Date:7/10/2014)... D.C., April 15, 2014 -- According to the ... to nuclear security comes from terrorists acquiring sufficient ... to construct a crude nuclear explosive device. The ... nuclear trafficking have involved gram-level quantities, which can ... , According to a new study appearing this ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Sensitive detection method may help impede illicit nuclear trafficking 2
... expands Dermagraft presence within government channels, ... 7 Advanced,BioHealing, Inc. (ABH) and Regenesis ... the promotion of Dermagraft(R) within the United,States ... the agreement,Regenesis will provide its specialized sales ...
... this Mother,s Day, STAMFORD, Conn., May 7 Every ... breast cancer(1). In New York City alone,more than 5,000 women ... the disease(2). While annual mammograms are recommended for,woman over the ... screening age do,not recognize how critical breast cancer screening is ...
... Inc., Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company, Federico ... FDA, ... IBC Life Sciences announced,the keynote line up for the ... to take place August 4-7, 2008 in,Boston, MA. The keynote ...
Cached Biology Technology:Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 2Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 3Fujifilm and the National Breast Cancer Foundation Provide Free Mammograms as Part of Images of Health Campaign 4Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress 2
(Date:7/11/2014)... Tenn., July 11, 2014--Researchers at the Department of ... R&D 100 awards, presented by R&D Magazine in ... , "These awards recognize the tremendous value of ... Moniz. "Research and development at the National Labs ... challenges and pursue the scientific and technological innovations ...
(Date:7/11/2014)... a new professorship in tissue engineering to promote ... Engineering and the Marine Biological Laboratory, supported by ... Eugene Bell Foundation., The Eugene Bell Professorship in ... Molecular Engineering. That endowed chair holder also will ... Bell Center for Regenerative Biology and Tissue Engineering, ...
(Date:7/11/2014)... 10, 2014---A team of researchers from The Chinese University ... a gene of wild soybean linked to salt tolerance, ... in saline soil. This study published online in ... novel genomic information for crop improvement. , Soybean is ... and human selection, cultivated soybeans have less genetic diversities ...
Breaking Biology News(10 mins):ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4New professorship in tissue engineering links molecular engineering, marine biology 2BGI reports a novel gene for salt tolerance found in wild soybean 2
... UK, July 20, 2011 - Recent clinical research ... [18F]Flutemetamol showed highly consistent image interpretation1 and showed ... ([C-11]PiB)) investigational imaging agent3. Flutemetamol is a GE ... currently in phase III development being studied for ...
... an arterial wall effectively protects the artery from developing ... published July 19 in the journal Molecular Therapy ... atherosclerosis, fatty lesions called plaques form on the inner ... restricting blood flow and causing chest pains and other ...
... A new Baylor University study has found that some bird ... some cases positively influenced, by widespread fire through their habitat. ... some bird species because of the habitat that is formed ... The study found that three specific bird species in ...
Cached Biology News:GE Healthcare studies report results of [18F]Flutemetamol research 2Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 2Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 3Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 4Study finds some desert birds less affected by wildfires and climate change 2
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
... This reagent has been developed for ... the reduction of nonspecific background staining ... methods describe blocking peroxidase with hydrogen ... peroxide in combination with additional novel ...
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
Formulation: 10mM PBS/500 mM NaCl, 0.09% NaN3, pH 7.2...
Biology Products: